GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » Net Issuance of Debt

Nuformix (LSE:NFX) Net Issuance of Debt : £0.00 Mil (TTM As of Sep. 2022)


View and export this data going back to 2015. Start your Free Trial

What is Nuformix Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Nuformix's net issuance of debt for the six months ended in Sep. 2022 was £0.00 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Sep. 2022 was £0.00 Mil.


Nuformix Net Issuance of Debt Historical Data

The historical data trend for Nuformix's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Net Issuance of Debt Chart

Nuformix Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Net Issuance of Debt
Get a 7-Day Free Trial - - - -0.08 -

Nuformix Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23
Net Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.08 - - - -

Nuformix Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuformix Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Nuformix's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuformix (LSE:NFX) Business Description

Traded in Other Exchanges
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.

Nuformix (LSE:NFX) Headlines

From GuruFocus

Newfield Exploration Company (NFX) EVP and CFO Terry W Rathert sells 40,000 Shares

By GuruFocus Research GuruFocus Editor 03-12-2010

Newfield Exploration Releases Second Quarter Report

By Black Iguana Nitish 09-30-2014

4 Independent Oil Drillers To Acquire Today

By Vatalyst.com Vatalyst.com 03-09-2012

Newfield Exploration Company (NFX) EVP and COO Gary D Packer sells 23,000 Shares

By GuruFocus Research GuruFocus Editor 03-11-2010